Processa Pharmaceuticals Stock Performance
| PCSA Stock | USD 0.24 0 1.25% |
On a scale of 0 to 100, Processa Pharmaceuticals holds a performance score of 3. The company holds a Beta of 0.26, which implies not very significant fluctuations relative to the market. As returns on the market increase, Processa Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Processa Pharmaceuticals is expected to be smaller as well. Please check Processa Pharmaceuticals' expected short fall, day typical price, and the relationship between the potential upside and daily balance of power , to make a quick decision on whether Processa Pharmaceuticals' historical price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Processa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:20 | Dividend Date 2019-12-23 | Last Split Date 2024-01-22 |
1 | PCSA Stock Placement by H.C. Wainwright Co. PCSA Stock News | 06/13/2025 |
2 | Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option ... | 06/17/2025 |
3 | Processa Pharmaceuticals Stock Soars 55.37 percent on Public Offering - AInvest | 06/20/2025 |
4 | Processa Pharmaceuticals Provides Portfolio and Business Update | 07/01/2025 |
5 | Transcript Processa Pharmaceuticals, Inc. - Special Call - MarketScreener | 07/09/2025 |
6 | Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks | 07/15/2025 |
7 | What drives Processa Pharmaceuticals Inc. stock price - Unbelievable profit margins - jammulinksnews.com | 07/22/2025 |
| Begin Period Cash Flow | 4.7 M | |
| Total Cashflows From Investing Activities | -3244.00 |
Processa Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 24.00 in Processa Pharmaceuticals on April 27, 2025 and sell it today you would earn a total of 0.28 from holding Processa Pharmaceuticals or generate 1.17% return on investment over 90 days. Processa Pharmaceuticals is currently generating 0.4263% in daily expected returns and assumes 9.1824% risk (volatility on return distribution) over the 90 days horizon. In different words, 82% of stocks are less volatile than Processa, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Processa Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Processa Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Processa Pharmaceuticals, and traders can use it to determine the average amount a Processa Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0464
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PCSA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.18 actual daily | 82 82% of assets are less volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Processa Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Processa Pharmaceuticals by adding it to a well-diversified portfolio.
Processa Pharmaceuticals Fundamentals Growth
Processa Stock prices reflect investors' perceptions of the future prospects and financial health of Processa Pharmaceuticals, and Processa Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Processa Stock performance.
| Return On Equity | -1.93 | ||||
| Return On Asset | -1.02 | ||||
| Current Valuation | 3.45 M | ||||
| Shares Outstanding | 26.19 M | ||||
| Price To Book | 1.79 X | ||||
| EBITDA | (11.85 M) | ||||
| Net Income | (11.85 M) | ||||
| Cash And Equivalents | 12.06 M | ||||
| Cash Per Share | 0.76 X | ||||
| Total Debt | 73.51 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 8.89 X | ||||
| Book Value Per Share | 0.67 X | ||||
| Cash Flow From Operations | (11.25 M) | ||||
| Earnings Per Share | (3.06) X | ||||
| Market Capitalization | 6.58 M | ||||
| Total Asset | 3.23 M | ||||
| Retained Earnings | (87.22 M) | ||||
| Working Capital | 340.99 K | ||||
About Processa Pharmaceuticals Performance
By analyzing Processa Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Processa Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Processa Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Processa Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 635.83 | 342.18 | |
| Return On Tangible Assets | (3.67) | (3.85) | |
| Return On Capital Employed | (7.10) | (6.75) | |
| Return On Assets | (3.67) | (3.85) | |
| Return On Equity | (6.99) | (6.64) |
Things to note about Processa Pharmaceuticals performance evaluation
Checking the ongoing alerts about Processa Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Processa Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Processa Pharmaceuticals had very high historical volatility over the last 90 days | |
| Processa Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (11.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Processa Pharmaceuticals currently holds about 12.06 M in cash with (11.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Processa Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: What drives Processa Pharmaceuticals Inc. stock price - Unbelievable profit margins - jammulinksnews.com |
- Analyzing Processa Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Processa Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Processa Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Processa Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Processa Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Processa Pharmaceuticals' stock. These opinions can provide insight into Processa Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |